Skip to main content
Search
Search
About Angelman Syndrome
About FAST
For Researchers
Welcome
Apply for a Grant
Grant Application Process
FAST-Funded Research
For Pharma
Welcome
The Pharma-Research-Community Hub
FAST Ventures
Resources
For Families & Caregivers
Welcome
Newly Diagnosed?
Understanding AS Genetics and Genotypes
Treatment & Trials
Get Involved
Resources for Caregivers
For Donors & Investors
Welcome
Ways to Give
Cure Angelman Now (CAN)
FAST Ventures
Contact Us
Donate
Donate
Menu
Welcome to the Foundation for Angelman Syndrome Therapeutics
We have one goal: to cure Angelman syndrome.
Save the Date!
FAST's 17th Annual Global Science Summit & Gala
For Researchers
For Pharma
For Families & Caregivers
For Donors & Investors
Not sure where to go? Start here.
Angelman Syndrome News
05/28/2024
CAN Spotlight: Kettlebells for Kayleigh
05/28/2024
FAST presents at the MENA Congress for Rare Diseases Angelman Symposium
05/28/2024
FAST France - Eye Study
05/21/2024
Congressional Advocacy Update
05/16/2024
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
05/14/2024
Purdue WellCast Study
05/14/2024
Understanding Clinical Outcome Assessments (COAs) Used in Clinical Trials
05/14/2024
Skating Angels host their Annual Hockey Tournament
04/30/2024
Newly published article on research exploring the epigenetic landscape of Angelman syndrome
04/30/2024
2023 CAN Grand Prize Trip
04/22/2024
FAST’s Genetic Services & Education
04/17/2024
April 17, 2024 Newsletter | What to Know
04/15/2024
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment...
04/01/2024
FAST LatAm Updates
04/01/2024
Welcoming FAST Germany
04/01/2024
Dr. Cesar Ochoa-Lubinoff
03/19/2024
Inaugural Angelman Syndrome Congressional Advocacy Day Round-Up
03/19/2024
Global Spotlight: Heather Brady
03/07/2024
Family Advocates Urge Congress’ Support During Inaugural Angelman Syndrome Congressional Advocacy Day
03/05/2024
How Clinical Trials Work
05/28/2024
CAN Spotlight: Kettlebells for Kayleigh
05/28/2024
FAST presents at the MENA Congress for Rare Diseases Angelman Symposium
05/28/2024
FAST France - Eye Study
05/21/2024
Congressional Advocacy Update
05/16/2024
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
05/14/2024
Purdue WellCast Study
05/14/2024
Understanding Clinical Outcome Assessments (COAs) Used in Clinical Trials
05/14/2024
Skating Angels host their Annual Hockey Tournament
04/30/2024
Newly published article on research exploring the epigenetic landscape of Angelman syndrome
04/30/2024
2023 CAN Grand Prize Trip
04/22/2024
FAST’s Genetic Services & Education
04/17/2024
April 17, 2024 Newsletter | What to Know
04/15/2024
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment...
04/01/2024
FAST LatAm Updates
04/01/2024
Welcoming FAST Germany
04/01/2024
Dr. Cesar Ochoa-Lubinoff
03/19/2024
Inaugural Angelman Syndrome Congressional Advocacy Day Round-Up
03/19/2024
Global Spotlight: Heather Brady
03/07/2024
Family Advocates Urge Congress’ Support During Inaugural Angelman Syndrome Congressional Advocacy Day
03/05/2024
How Clinical Trials Work